文献速递乳房整形与再造

组织扩张器放疗后乳房再造患者的生活质量:倾向性匹配初步分析

Quality of Life in Breast Reconstruction Patients after Irradiation to Tissue Expander: A Propensity-Matched Preliminary Analysis.
PubMed 文献 · Plast Reconstr Surg · 2023-02-01

该研究对341例接受组织扩张器及乳房切除术后放疗(PMRT)的患者进行倾向性匹配初步分析,匹配后纳入106例(自体乳房再造ABR组53例与假体乳房再造IBR组53例),比较两组并发症与BREAST-Q评分。结果显示ABR组在再造后各时间点的乳房满意度评分均高于IBR组(差异大于4分最小临床重要差值,P<0.05),其他BREAST-Q领域及并发症发生率无显著差异。作者认为需要更大样本的匹配研究来改善共同决策。

要点

  • 匹配后ABR组乳房满意度评分在再造后各时间点均高于IBR组(P<0.05)。
  • 两组其他BREAST-Q领域评分及再造后并发症发生率无显著差异。
  • 作者认为需要更大样本的匹配研究以改善患者共同决策。

核心结论

  • 在该匹配初步分析中,组织扩张器放疗后行自体乳房再造的患者乳房满意度评分优于假体乳房再造患者。
  • 作者认为需要更大样本的匹配研究以改善需要乳房切除及PMRT患者的共同决策。

研究设计与样本

  • 倾向性评分初步分析(1:1匹配,无放回),比较组织扩张器及PMRT后行自体乳房再造(ABR)或假体乳房再造(IBR)的患者。
  • 匹配协变量包括年龄、种族/民族、吸烟状态、体重指数、精神科诊断史及再造侧别。
  • 341例接受组织扩张器及PMRT的患者中,共106例纳入匹配分析:ABR组53例,IBR组53例。
  • 研究为治疗性研究,证据等级III。

主要发现

  • ABR组与IBR组在匹配基线、癌症及手术特征方面无显著差异。
  • ABR组在再造后所有时间点的乳房满意度评分均高于IBR组(差异大于4分最小临床重要差值,P<0.05)。
  • 其他BREAST-Q领域(胸部躯体健康、性健康、心理社会健康)术后无显著差异。
  • 最终再造后并发症发生率在两组间无显著差异。

关键数值与推荐

  • 乳房满意度评分差异大于4分最小临床重要差值,P<0.05,ABR组高于IBR组。
  • 其他BREAST-Q领域及并发症发生率组间无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文标题及摘要将研究描述为初步分析(preliminary analysis)。
  • 作者在结论中指出需要更大样本的匹配研究(higher powered matched studies)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tissue expanders (TEs) are routinely placed as a first step in breast reconstruction for women who require postmastectomy radiation therapy (PMRT). The final reconstruction can then be performed with implants or conversion to autologous tissues. The purpose of this study was to compare patient-reported outcomes and surgical complications in autologous (ABR) versus implant-based breast reconstruction (IBR) patients following TE-PMRT. METHODS: The authors performed a propensity score preliminary analysis (1:1 matching, no replacement) in patients undergoing ABR or IBR following TE-PMRT. Matched covariates included age, race/ethnicity, smoking status, body mass index, history of psychiatric diagnosis, and laterality of reconstruction. Outcomes of interest included complications and BREAST-Q scores for Satisfaction with Breasts, Physical Well-Being of the Chest, Sexual Well-Being, and Psychosocial Well-Being domains. RESULTS: Of 341 patients with TE-PMRT, a total of 106 patients were included in the matched analysis: 53 ABR patients and 53 IBR patients. ABR and IBR did not differ significantly in matched baseline, cancer, and surgical characteristics. ABR patients had higher scores for Satisfaction with Breasts (greater than the four-point minimal clinically important difference) at all postreconstruction time points compared with IBR patients ( P < 0.05). There were no significant postoperative differences in other BREAST-Q domains. The incidence of complications after definitive reconstruction did not differ significantly among cohorts. CONCLUSIONS: In this matched preliminary analysis, patients who underwent ABR following irradiation to a TE demonstrated superior satisfaction with breast scores compared with IBR patients. Higher powered matched studies are needed to improve shared decision-making for patients who require mastectomy and PMRT as part of their treatment. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Polanco TO, Shamsunder MG, Parikh RP, et al. Quality of Life in Breast Reconstruction Patients after Irradiation to Tissue Expander: A Propensity-Matched Preliminary Analysis. Plast Reconstr Surg. 2023. PMID: 36724013. doi:10.1097/PRS.0000000000010249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。